Clinical trial / 2016
Consuming kale at 7 g or 14 g with a high-carbohydrate meal suppressed postprandial plasma glucose increases in Japanese adults.
In a randomized, double-blind, placebo-controlled crossover trial, 42 Japanese subjects consumed placebo or kale-containing food (7 g active-L or 14 g active-H) with a high-carbohydrate meal. Maximum plasma glucose concentrations (Cmax) were significantly lower for active-L (163±24 mg/dl) and active-H (162±23 mg/dl) compared with placebo (176±26 mg/dl; P<0.01). Glucose AUC0-2 h was also significantly lower for active-L (268±43 mg/h/dl) and active-H (266±42 mg/h/dl) versus placebo (284±43 mg/h/dl; P<0.05). No significant differences were found in postprandial plasma insulin levels, and no adverse events were observed.
- Study type
- Randomized, double-blind, placebo-controlled, crossover trial
- Who was studied
- 42 Japanese subjects aged 21-64 years with fasting plasma glucose <=125 mg/dl and 30-min postprandial glucose 140-187 mg/dl
- What was measured
- Postprandial plasma glucose and insulin levels, Cmax, and AUC0-2 h
THE PAPER
Intake of kale suppresses postprandial increases in plasma glucose: A randomized, double-blind, placebo-controlled, crossover study.
Kondo S, Suzuki A, Kurokawa M, Hasumi K. Biomed Rep, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.